Nathan 2008: ADAG Study - Translating A1C to Average Glucose
Nathan et al. • Diabetes Care
Key Finding
eAG (mg/dL) = 28.7 × A1C − 46.7 allows conversion of A1C to average glucose
Original title: “Translating the A1C assay into estimated average glucose values”
Plain English Summary
The A1C-Derived Average Glucose (ADAG) study established the mathematical relationship between HbA1c and estimated average glucose (eAG). Formula: eAG (mg/dL) = 28.7 × A1C − 46.7
In-Depth Analysis
Background
Dr. David M. Nathan and the A1C-Derived Average Glucose (ADAG) Study Group published this landmark study in Diabetes Care (PMID: 18540046), establishing the mathematical relationship between HbA1c and average glucose.
Study Design
Design: Prospective observational study Population: 507 participants (268 type 1 diabetes, 159 type 2 diabetes, 80 non-diabetic) Methods:
- •HbA1c measured monthly for 3 months
- •Continuous glucose monitoring (CGM) for 48 hours each month
- •Self-monitored blood glucose 7+ times daily
- •Linear regression to derive relationship
Key Findings
The ADAG formula:
eAG (mg/dL) = 28.7 × A1C − 46.7
eAG (mmol/L) = 1.59 × A1C − 2.59
Correlation: r = 0.92 (excellent)
| A1C (%) | eAG (mg/dL) | eAG (mmol/L) |
|---|---|---|
| 5.0 | 97 | 5.4 |
| 6.0 | 126 | 7.0 |
| 7.0 | 154 | 8.6 |
| 8.0 | 183 | 10.2 |
| 9.0 | 212 | 11.8 |
| 10.0 | 240 | 13.4 |
Mechanistic Insights
HbA1c reflects average glucose exposure over RBC lifespan (~120 days), weighted toward recent weeks. The linear relationship allows conversion to glucose units more intuitive for patients.
Limitations:
- •Individual variation exists (±15 mg/dL at any A1C)
- •Conditions affecting RBC lifespan alter the relationship
Clinical Implications
The eAG conversion allows patients to understand their A1C in familiar glucose units. However, eAG is a population average—individual variation means it may not match a specific patient's true average.
Metabolic Health Perspective
For metabolic optimization, direct glucose measurement (CGM or frequent monitoring) provides superior insight into patterns, variability, and postprandial spikes that eAG cannot capture. A1C/eAG remain useful for long-term trending.
Paradigm Relevance
How this study applies to different clinical perspectives:
Standard Medical
RelevantConventional clinical guidelines used by most doctors
Research Consensus
RelevantCurrent scientific understanding, often ahead of guidelines
Metabolic Optimization
RelevantProactive targets for optimal health, not just disease absence
Study Details
- Type
- Cohort Study
Related Biomarkers
Calculate & Evaluate on Metabolicum
Original Source
DOI (Digital Object Identifier) is a permanent link to this publication. Unlike website URLs that can change, a DOI always resolves to the correct source.
Related Studies
Unwin 2020: Low Carb Diet in Type 2 Diabetes - General Practice Evidence
Unwin D et al. • BMJ Nutrition Prevention & Health • 2020
Lower carbohydrate dietary advice in primary care led to significant improvements in HbA1c, weight, and medication reduction
Insights from a general practice service evaluation supporting a lower carbohydrate diet in patients with type 2 diabetes mellitus and prediabetes: a secondary analysis of routine clinic data including HbA1c, weight and prescribing over 6 years
Unwin et al. • BMJ Nutrition, Prevention & Health • 2020
T2D drug-free remission: 46% (59/128); HbA1c 65.5→48 mmol/mol (P<0.001); weight 99.7→91.4 kg; prediabetes: 93% normalized HbA1c; £50,885/year prescription savings
Proton Pump Inhibitors, H2-Receptor Antagonists, Metformin, and Vitamin B-12 Deficiency: Clinical Implications
Miller JW • Advances in Nutrition • 2018
PPIs/H2RAs: HR 1.83 (95% CI 1.36-2.46) for B12 deficiency with ≥10 months use; Metformin: mean B12 reduction of -54 pmol/L (95% CI -81 to -26)